Jeffrey S. Martini - 13 Dec 2024 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
Chief Scientific Officer
Signature
Kathleen A. McGowan, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
13 Dec 2024
Net transactions value
$0
Form type
4
Filing time
17 Dec 2024, 20:44:04 UTC
Next filing
10 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVLA Stock Option (right to buy) Award $0 +126,416 $0.000000 126,416 13 Dec 2024 Common Stock 126,416 $13.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in equal monthly tranches over 48 months.